Skip to main content
. 2020 Aug 15;78(12):2138–2146. doi: 10.1016/j.joms.2020.08.012

Figure 2.

Figure 2

Histomorphometric and immunostaining profile of interleukin (IL)-6 in dental alveoli three days after exodontia and treatment with varying doses of tocilizumab (TCZ) showing a reduction in Howship lacunae and osteoclasts close to the bone and an increase in polymorphonuclear cells in TCZ32 group. Histologic magnification: 400x (H&E); IHC magnification: 400x (Dab/Harris hematoxylin).